Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
1668038
Reference Type
Journal Article
Title
Treating wastewater from a pharmaceutical formulation facility by biological process and ozone
Author(s)
Lester, Y; Mamane, H; Zucker, I; Avisar, D
Year
2013
Is Peer Reviewed?
1
Journal
Water Research
ISSN:
0043-1354
EISSN:
1879-2448
Volume
47
Issue
13
Page Numbers
4349-4356
Language
English
PMID
23764586
DOI
10.1016/j.watres.2013.04.059
Web of Science Id
WOS:000323240100016
Abstract
Wastewater from a pharmaceutical formulation facility (TevaKS, Israel) was treated with a biological activated-sludge system followed by ozonation. The goal was to reduce the concentrations of the drugs carbamazepine (CBZ) and venlafaxine (VLX) before discharging the wastewater to the municipal wastewater treatment plant (WWTP). Both drugs were detected at extremely high concentrations in TevaKS raw wastewater ([VLX]=11.72±2.2mg/L, [CBZ]=0.84±0.19mg/L), and resisted the biological treatment. Ozone efficiently degraded CBZ: at an O3 dose-to-dissolved organic carbon ratio of 0.55 (O3/DOC), the concentration of CBZ was reduced by >99%. A lower removal rate was observed for VLX, which was decreased by ∼98% at the higher O3/DOC ratio of 0.87. Decreasing the pH of the biologically treated effluent from 7 to 5 significantly increased the ozone degradation rate of CBZ, while decreasing the degradation rate of VLX. Ozone treatment did not alter the concentration of the effluent's DOC and filtered chemical oxygen demand (CODf). However, a significant increase was recorded (following ozonation) in the effluent's biological oxygen demand (BOD5) and the BOD5/CODf ratio. This implies an increase in the effluent's biodegradability, which is highly desirable if ozonation is followed by a domestic biological treatment. Different organic byproducts were formed following ozone reaction with the target pharmaceuticals and with the effluent organic matter; however, these byproducts are expected to be removed during biological treatment in the municipal WWTP.
Keywords
Pharmaceutical; Formulation facility; Ozone; Carbamazepine; Venlafaxine
Tags
NAAQS
•
ISA-Ozone (2020 Final Project Page)
Literature Search Results
Literature Search - Excluded
Keyword Search Excluded
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity